Site-Specific Factor 23
Multigene Signature Results
Notes
**Note 1:** The results for the Oncotype DX test are expressed as a percentage Recurrence Score ranging from 0 to 100, with risk assessment in the categories of low, intermediate, and high. * Record the score which can be found in the orange circle **Note 2:** The results for the MammaPrint test are expressed as low risk for distant recurrence and high risk for distant recurrence. **Note 3:** Code the score or results of the multigene signature assay recorded in **Site-Specific Factor 22, Multigene Signature Method**. * Code the percentage score for Oncotype DX, if available, in preference to the risk assessment * Code the risk assessment for MammaPrint **Note 4:** This information may not be available at diagnosis and may require follow-up with the physician.Default
999NAACCR Item
NAACCR #2877Metadata
None| Code | Description |
|---|---|
| 000-100 | Score of 000 - 100 (Actual score with leading zeroes to nearest whole percentage) |
| 200 | Low risk of recurrence (good prognosis) |
| 300 | Intermediate risk of recurrence |
| 400 | High risk of recurrence (poor prognosis) |
| 988 | Not applicable: Information not collected for this case |
| 997 | Test ordered, results not in chart |
| 998 | Test not done (test not ordered and not performed) |
| 999 | Unknown or no information Not documented in patient record |